Visual laser ablation of the prostate was performed on 108 patients (a
ges 44 to 84 years) as an outpatient procedure from May 1992 to Octobe
r 1992. Preoperatively, the patients underwent digital rectal examinat
ions, determination of prostate specific antigen levels and transrecta
l ultrasound guided biopsies when necessary to rule out the presence o
f prostate cancer. The Urolase laser fiber delivery system was used to
transmit laser energy from a neodymium: YAG generator. For the 97 pat
ients with preoperative and postoperative American Urological Associat
ion symptom index testing, scores decreased by an average of 12.59 (p
< 0.001). For the 75 patients with preoperative and postoperative urof
low rates an average increase of 4.92 ml. per second (p < 0.001) was n
oted following the procedure. Only 3 patients required hospitalization
for an average of 1.33 days. No patient required a blood transfusion.
There have been no fluid or electrolyte abnormalities following visua
l laser ablation of the prostate. There have been no recognizable uret
hral strictures, deaths or postoperative sepsis. Only 3 patients exper
ienced retrograde ejaculation. We found visual laser ablation of the p
rostate to be a cost-effective and less morbid alternative to traditio
nal transurethral resection of the prostate.